Results 1 to 10 of about 9,872 (176)
Case Reports in Cardiology, 2022 Background. Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Mingkui Zhang +4 more
doaj +2 more sources
Is distortion of the bioprosthesis ring a risk factor for early calcification ? [PDF]
Journal of Cardiothoracic Surgery, 2010 Background As the population ages, bioprosthesis are increasingly being used in cardiac valve replacement. Pericardial bioprosthesis combine an excellent hemodynamic performance with low thrombogenicity, but valve failure associated with calcification ...
de Alegria Anxo +4 more
doaj +3 more sources
Transfermoral aortic valve implantation using self-expanding New Valve Technology (NVT) Allegra bioprosthesis: A pilot prospective study [PDF]
Cardiology Journal, 2021 BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become a standard therapeutic option for patients with severe aortic stenosis (AS) at high cardiac surgical risk.
Dariusz Jagielak +7 more
doaj +4 more sources
Clinical Case Reports, 2021 Transseptal TMViV should be considered for mitral bioprosthesis failure especially when large THV can be implanted. Elevated residual mean gradient and its effect on valve durability and potential valve thrombosis remains an unanswered question.
Nils Perrin +2 more
doaj +2 more sources
Late leaflet dehiscence in a bovine bioprosthesis-mimicked COVID-19 infection
SAGE Open Medical Case Reports, 2021 Symptoms mimicking COVID-19 infection, pulmonary emboli, or septicemia delayed diagnosis of aortic bioprosthesis failure. A 71-year-old man was admitted emergently with shortness of breath, fever, cough, and chest pain. Echocardiography performed after 2
Torbjörn Ivert, Magnus Dalén
doaj +2 more sources
Matryoshka procedure for Valve‐in‐Valve TAVI failure
Clinical Case Reports, 2022 Valve‐in‐valve transcatheter valve implantation (ViV‐TAVI) procedures for deteriorated bioprosthesis are an established therapeutic option for high‐risk patients. The presence of the fixed sewing ring of the bioprosthesis can hamper appropriate expansion
Vittoria Lodo +7 more
doaj +1 more source
Yersinia enterocolitica endocarditis on aortic bioprosthesis: A case report
IDCases, 2022 Yersinia enterocolitica is a Gram-negative bacillus and an unusual cause of endocarditis. We report the first case of a 74-year-old woman who developed a Yersinia enterocolitica endocarditis on an aortic bioprosthesis.
Marin Delaunay +2 more
doaj +1 more source
Early surgical aortic bioprosthesis failure caused by cusp tear: A word of caution
Clinical Case Reports, 2021 Cusp tear is an increasingly described mode of failure of the Trifecta aortic bioprosthesis. Acute aortic regurgitation after implantation of a Trifecta in absence of endocarditis should suggest a cusp tear and be promptly treated with redo surgery.
Thibault Schaeffer +2 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Background: Bioprosthetic heart valve has limited durability and lower long-term performance especially in rheumatic heart disease (RHD) patients that are often subject to multiple redo operations.
Mariana Pezzute Lopes +13 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2023 IntroductionCalcification is a main cause of bioprosthetic heart valves failure. It may be promoted by the inflammation developed in the glutaraldehyde (GA)-fixed cusps of the bioprosthesis. We tested the hypothesis that antagonizing the C-X-C chemokines
Yuthiline Chabry +9 more
doaj +1 more source